Author: Kim, Dong Soon
Title: Acute Exacerbation of Idiopathic Pulmonary Fibrosis Cord-id: 768v973w Document date: 2019_12_31
ID: 768v973w
Snippet: Abstract Acute exacerbation is a major cause of morbidity and mortality in patients with idiopathic pulmonary fibrosis. Although the real nature of it is still not clear and there is no proven effective therapy, progress has been made since the consensus definition and diagnostic criteria were proposed. The trial results of several new innovative therapies in idiopathic pulmonary fibrosis have suggested a potential for benefit in acute exacerbation of idiopathic pulmonary fibrosis, leading to do
Document: Abstract Acute exacerbation is a major cause of morbidity and mortality in patients with idiopathic pulmonary fibrosis. Although the real nature of it is still not clear and there is no proven effective therapy, progress has been made since the consensus definition and diagnostic criteria were proposed. The trial results of several new innovative therapies in idiopathic pulmonary fibrosis have suggested a potential for benefit in acute exacerbation of idiopathic pulmonary fibrosis, leading to double blind randomized clinical trials in this area. This article reviews the present knowledge on acute exacerbation of idiopathic pulmonary fibrosis, focusing on the triggering factors and treatment.
Search related documents:
Co phrase search for related documents- aberrant proinflammatory cytokine and acute respiratory: 1
- aberrant proinflammatory cytokine and lung function: 1
Co phrase search for related documents, hyperlinks ordered by date